1. ICH M7 (R1).Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. Current Step 4 version dated 31 March 2017.
2. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
3. Recent advances in trace analysis of pharmaceutical genotoxic impurities
4. Vanhoenacker G. David F. andSandra P.(2011).Sensitivity enhancement for potential genotoxic impurity determination using the Agilent 1290 Infinity LC System and a 60 mm Agilent Max‐Light Cartridge Cell. Agilent Technologies Publication Number 5990‐7443EN.